Clinical trials sponsored by Rapport Therapeutics Inc.

Phase breakdown

Conditions studied

Recruiting trials led by Rapport Therapeutics Inc.

• A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
  NCT07219407 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 7 locations
• Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
  NCT07594119 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 11 locations
• Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
  NCT07563881 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 11 locations

Common questions

How many trials is Rapport Therapeutics Inc. recruiting for?

Rapport Therapeutics Inc. is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.